Why the Certificate of Analysis Is Your First Line of Quality Control
Every vial of research peptide arrives with a document that tells you far more than its label ever could. The Certificate of Analysis (COA) is a supplier-issued report summarizing the analytical data collected for a specific batch of peptide. For researchers designing experiments that depend on precisely known concentrations and confirmed molecular identities, understanding each field of a COA is not optional—it is fundamental to experimental integrity.
This guide walks through the standard sections of a peptide COA, explains what each measurement means, and highlights the thresholds and red flags researchers should look for before any peptide enters the workflow.
Batch and Lot Identification
At the top of every COA you will find batch or lot number, synthesis date, and sometimes an expiry or retest date. These identifiers link the physical material in your hands to a permanent analytical record. Always verify that the lot number printed on the vial matches the lot number on the COA. A mismatch—however it occurs—means you cannot trust that the analytical data applies to your sample.
The synthesis or manufacture date matters for stability planning. Most lyophilized peptides are stable for 24–36 months when stored correctly, but peptides containing oxidation-prone residues such as methionine or tryptophan, or those with free cysteine thiols, may warrant closer attention to elapsed time since synthesis.
Purity: The Most-Cited Metric
Purity is typically expressed as a percentage and is almost universally determined by reverse-phase high-performance liquid chromatography (RP-HPLC). The instrument separates the target peptide from deletion sequences, truncated fragments, oxidized variants, and other synthesis byproducts based on hydrophobicity. The area under the main peak is divided by the total integrated area of all peaks, yielding the percent purity.
Interpreting HPLC Purity Values
- ≥ 95% purity: The standard benchmark for most in vitro biochemical and cell-based assays. At this level, impurities are unlikely to drive artifact signals in most experimental contexts.
- ≥ 98% purity: Recommended for structural studies, receptor-binding assays, or any application where a minor impurity could co-elute with the target and confound results.
- < 90% purity: Generally unsuitable for quantitative research without additional purification; impurity peaks may have their own biological or physicochemical activity.
The COA should specify the HPLC column type (C18 is most common), the detection wavelength (typically 214 nm or 220 nm to capture the peptide bond absorbance), and the gradient conditions used. This information allows an independent laboratory to reproduce the analysis if needed.
Mass Spectrometry: Confirming Molecular Identity
Purity alone does not confirm that the correct peptide was synthesized. A highly pure sample could theoretically be a truncation or a scrambled sequence with a similar retention time. Mass spectrometry (MS) provides the complementary identity confirmation by measuring the mass-to-charge ratio (m/z) of the intact molecule.
The COA will report the theoretical molecular weight (calculated from the amino acid sequence and any modifications) alongside the observed molecular weight derived from the MS spectrum. For research-grade peptides, these values should agree within ±0.5 Da for peptides up to approximately 3,000 Da, and within ±1–2 Da for larger sequences, depending on the instrument and ionization method.
Common MS Methods Reported
- ESI-MS (Electrospray Ionization): Produces multiply charged ions; well-suited to larger peptides and provides high mass accuracy.
- MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization – Time of Flight): Typically generates singly charged ions; favored for rapid batch screening and larger peptides.
When reading the MS data, confirm that the observed mass matches the expected value for the specified modification state—for example, a disulfide-bonded peptide will show a mass 2 Da lower than its reduced linear form. If the COA reports only the linear mass for a cyclic peptide, request clarification from the supplier.
Water Content: Why Net Peptide Content Matters
Lyophilized peptides are hygroscopic. The white powder in your vial contains not only peptide but also residual water and, frequently, counter-ions such as trifluoroacetate (TFA) or acetate that co-precipitate during lyophilization. A COA that reports purity by HPLC but does not account for water content will lead you to overestimate the true peptide mass you are weighing out.
Karl Fischer titration is the gold-standard method for determining water content, and its result is expressed as a weight percentage. A typical lyophilized peptide may contain 5–15% water by mass. If the COA reports a water content of 10%, then a nominally 1 mg vial contains approximately 0.90 mg of peptide-containing solid—and of that solid, only the HPLC purity fraction represents the target sequence.
Some suppliers provide a net peptide content (NPC) figure that combines purity and water content into a single correction factor. When NPC is available, use it to calculate stock concentrations rather than relying on the nominal vial weight alone.
Additional Tests You May Encounter
- Amino acid analysis (AAA): Hydrolysis of the peptide followed by quantification of constituent amino acids; confirms composition and supports absolute quantity determination.
- Sterility and endotoxin testing: Relevant for cell culture applications; LAL assay results are expressed in EU/mg. Not all research peptide suppliers perform these tests as standard.
- Counter-ion content: TFA is a common synthesis artifact with reported cytotoxic effects at high concentrations in cell culture. Some COAs report TFA levels; if yours does not, consider ion-exchange or HPLC-based counter-ion replacement before cell-based work.
- Optical rotation or chiral purity: Relevant for peptides where D-amino acid substitution is intentional and must be verified.
Cross-Checking the COA Against Your Experimental Needs
Before accepting a COA as sufficient for your application, run through this practical checklist:
- Does the lot number on the document match the vial label exactly?
- Is HPLC purity at or above the threshold your assay requires?
- Does the observed MS mass match the theoretical mass within acceptable tolerance for your peptide's size?
- Is water content reported, and have you factored it into your stock solution calculations?
- Are any modifications (acetylation, amidation, disulfide bonds, PEGylation) explicitly confirmed rather than assumed?
- Is the storage recommendation on the COA consistent with your laboratory's capabilities?
If any field is absent or ambiguous, contact the supplier for the underlying raw data—reputable manufacturers retain chromatograms, spectra, and titration records and can provide them upon request.
Maintaining Your Own COA Archive
Good laboratory practice dictates that COAs be retained alongside experimental notebooks and linked to the specific experiments in which each batch was used. If a result is later questioned, the ability to trace back to the exact batch, its analytical data, and storage history is invaluable. Digital archiving with lot-number-based file naming simplifies this considerably.
For research use only. The information in this article is intended for trained laboratory professionals conducting in vitro or preclinical research. It does not constitute medical advice, dosing guidance, or encouragement of any human or veterinary therapeutic use.